Don Creighton
Articles
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 25th 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More
Latest Updated Articles
Published: November 22nd 2024 | Updated: November 24th 2024
A Transparent, Patient-First Approach Amid Ongoing PBM Industry Challenges
Published: November 20th 2024 | Updated: November 24th 2024
Binghamton University, Mayo Clinic and Others Snare NIH Funding for IBD Research
Published: November 5th 2024 | Updated: November 24th 2024
The Mainstreaming of CAR-T
Published: November 18th 2024 | Updated: November 24th 2024
FDA Approves First-in-Class Drug for Rare Leukemia
Published: November 19th 2024 | Updated: November 24th 2024
Lung Association, Merck Partner to Raise Awareness of PAH
Published: May 8th 2024 | Updated: November 24th 2024
FDA Sets Date for Advisory Committee Meeting for Midomafetamine for PTSD
